The Clinical and Scientific Operations team at Gyroscope Therapeutics is responsible for overseeing the design and execution of clinical trials related to retinal gene therapies. This multidisciplinary team collaborates closely with scientific and clinical advisory board members, researchers, and operational experts to ensure robust protocol development, regulatory compliance, and quality control in the advancement of innovative treatments for dry age-related macular degeneration. Their work is crucial in bridging laboratory research with clinical application, ultimately aiming to improve patient outcomes in vision health.
Alberto Auricchio
Scientific Advisory Board Memb...
Claire Harris
Scientific Advisory Board Memb...
David Steel
Scientific Advisory Board Memb...
Jane Hughes
Chief Scientific Officer
Keith Peters
Scientific Advisory Board Memb...
Matthew Pickering
Scientific Advisory Board Memb...
Nadia Waheed
Chief Medical Officer
Pete Coffey
Scientific Advisory Board Memb...
Robert Maclaren
Scientific Advisory Board Memb...
Timothy Stout
Scientific Advisory Board Memb...